Opal Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Opal Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$468K	Sell	896 -211	-19%	-$108K	0.1%	109
2026 Q2	$550K	Buy	1,107 +517	+88%	+$229K	0.12%	88
2026 Q1	$263K	Buy	590 +29	+5%	+$13.5K	0.06%	167
2025 Q4	$254K	Buy	+561	New	+$242K	0.07%	176
2025 Q3	–	Sell	-164	Closed	-$73K	–	544
2025 Q2	$73K	Sell	164 -5	-3%	-$2.3K	0.02%	313
2025 Q1	$81.9K	Buy	+169	New	+$78.8K	0.03%	295
2024 Q3	–	Sell	-124	Closed	-$58.1K	–	1149
2024 Q2	$58.1K	Sell	124 -10	-7%	-$4.34K	0.02%	339
2024 Q1	$56K	Buy	+134	New	+$56.6K	0.02%	207

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Opal Wealth Advisors's VRTX Position: Q3 2026 in Review

Opal Wealth Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 19% in Q3 2026, selling an estimated $108K and leaving 896 shares worth $468K. The position accounts for 0.1% of the portfolio, ranked #109.

Opal Wealth Advisors first reported a position in VRTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $550K in Q2 2026. 366 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Opal Wealth Advisors held 896 shares of Vertex Pharmaceuticals worth $468K as of Q3 2026.
Opal Wealth Advisors sold 211 Vertex Pharmaceuticals shares in Q3 2026, an estimated $108K.
Vertex Pharmaceuticals made up 0.1% of Opal Wealth Advisors's portfolio in Q3 2026, its #109 holding.
Opal Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
Opal Wealth Advisors's Vertex Pharmaceuticals position peaked at $550K in Q2 2026.
366 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Opal Wealth Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.